Our Innovation Prize | Partnering
Established in 2015 and jointly sponsored by BI and the BI Venture Fund, the prize allows recipients to focus on development of breakthrough medicines.
Search
Office Hours Program | Partnering
Click here to find out how Boehringer Ingelheim's pioneering ‘Office Hours’ program has now mentored over 250 early-stage companies since 2015.
partnering-oncology-cancer-immunology.pdf
Partnering-Mental-Health-Disorders_0.pdf
research-beyond-borders-partnering.pdf
Partnering-Mental-Health-Disorders.pdf
partnering-cardiometabolic_0.pdf
retinal-health-partnering-interests.pdf
partnering-cardiometabolic.pdf
Partnering in Biotherapeutics Technologies
AH-Partnering-Cardiometabolic-Diseases.pdf
technology-partnering-interests.pdf
Partnering-Boehringer-Ingelheim.pdf
partnering-immunology-respiratory-diseases.pdf
AH-Partnering-CNS-Diseases.pdf
AH-Partnering-Technologies.pdf
Partnering in Technologies
ww-partnering-contacts_0.pdf
Boehringer Ingelheim Partners with Thoeris to Investigate a Novel Approach to Treat Urea Cycle Disorders
Boehringer Ingelheim Partners with Thoeris to Investigate a Novel Approach to Treat Urea Cycle Disorders
BI Beyond Borders: Science, Collaboration, Geography | BI US
Read more on how the Company’s ‘radar’ for the next big wave of innovation, the RBB team, is tasked with exploring emerging science and technologies.
Meet our Team
Meet Our Team
Life forward - Boehringer Ingelheim unveils its evolved company brand
Life forward - Boehringer Ingelheim unveils its evolved company brand
Working Together in Human Health
Working Together in Human Health
Purchasing
Suppliers are an integral part of our success. We are passionate about solutions and new opportunities to review, improve and optimize our supplier base.
Therapeutics
Therapeutics